ASX Share rice
Sun 16 May 2021 - 01:29:am (Sydney)

LGP Share Price

LITTLE GREEN PHARMA LTDLGPPharmaceuticals, Biotechnology & Life Sciences

LGP Company Information

Name:

Little Green Pharma Ltd

Sector:

Healthcare

Industry:

Drug Manufacturers-Specialty & Generic

Address:

Level 2 West Perth WA Australia 6005

Phone:

61 8 6280 0050

MD & Director:

Ms. Fleta Jennifer Solomon

Exec. Director:

Mr. Angus McDougall Caithness

Chief Operating Officer:

Mr. Paul Long

Gen. Counsel & Company Sec.:

Mr. Alistair Warren B.A., L.L.B.

Head of Marketing:

Ms. Celia Young

Head of People & Systems:

Ms. Holly Birch

Head of Research & Innovation:

Dr. Leon Warne

Head of Quality:

Ms. Lina Sandberg

Company Overview:

Little Green Pharma Ltd engages in the research and development, cultivation, production, manufacturing, and distribution of medicinal cannabis products in Australia and internationally. It offers a range of medical cannabis preparations in oil formulation under the LGP Natural and LGP Advanced names. The company was founded in 2016 and is headquartered in West Perth, Australia.

LGP Share Price Information

Shares Issued:

187.28M

Market Capitalisation:

$124.54M

Revenue (TTM):

$5.26M

Revenue Per Share (TTM):

$0.03

Earnings per Share:

$-0.0372

Profit Margin:

-0.6324

Operating Margin (TTM):

$-0.81

Return On Assets (TTM):

$-0.19

Return On Equity (TTM):

$-0.75

Quarterly Revenue Growth (YOY):

4.267

Gross Profit(TTM):

$1.15M

Diluted Earnings Per Share (TTM):

$-0.021

LGP CashFlow Statement

CashFlow Date:

2020-06-30

Investments:

$-7,080,054

Change To Liabilities:

$47.53K

Total Cashflow From Investing Activities:

$-7,080,054

Net Borrowings:

$8.77M

Net Income:

$-9,315,435

Total Cash From Operating Activities:

$-6,048,567

Depreciation:

$368.19K

Other Cashflow From Investing Activities:

$-269,532

Change To Inventory:

$-816,070

Change To Account Receivables:

$-541,377

Sale Purchase Of Stock:

$10M

Capital Expenditures:

$6.33M

LGP Income Statement

Income Date:

2020-06-30

Income Before Tax:

$-9,315,440

Net Income:

$-9,315,440

Gross Profit:

$1.12M

Operating Income:

$-7,275,980

Interest Expense:

$327.37K

Total Revenue:

$2.20M

Cost Of Revenue:

$1.08M

LGP Balance Sheet

Balance Sheet Date:

2020-06-30

Intangible Assets:

$620.38K

Total Liabilities:

$4.11M

Total Stockholder Equity:

$12.30M

Total Assets:

$16.40M

Common Stock:

$29.94M

Other Current Assets:

$13.86K

Retained Earnings:

$-18,808,528

Other Assets:

$340.23K

Cash:

$4.27M

Total Current Liabilities:

$2.66M

Property - Plant & Equipment:

$9.14M

Net Tangible Assets:

$11.68M

Long-Term Investments:

$340.23K

Total Current Assets:

$6.30M

Net Receivables:

$629.66K

Short-Term Investments:

$10.10M

Inventory:

$1.36M

Accounts Payable:

$1.47M

Short-Term Investments:

$10.10

Non Current Liabilities Total:

$1.45M

LGP Share Price History

LGP News

11 Feb, 2021
The big shareholder groups in Little Green Pharma Ltd ( ASX:LGP ) have power over the company. Large companies usually...
20 Jul, 2020
Highlights: LGP granted ODC Medical Cannabis Cultivation and Production Permit for its expanded cultivation and manufacturing facility in Australia.Expanded Cultivation and.
28 May, 2020
April 2020 - a record sales month with 1,850+ units sold, a 17% increase on March 2020 (previous record sales month)380 new patients prescribed LGP products in April (for a.